RNSHF: AI 评分 54/100 — AI 分析 (4月 2026)

Renishaw plc is a global engineering and scientific technology company specializing in metrology and healthcare products. The company provides advanced solutions for industries requiring high precision measurement and process control.

Key Facts: AI Score: 54/100 Sector: Technology

公司概况

概要：

Renishaw plc, a UK-based engineering and scientific technology firm, delivers metrology and healthcare solutions worldwide. With a focus on precision measurement and process control, Renishaw serves diverse sectors including aerospace, automotive, and healthcare, leveraging its innovative product portfolio and global distribution network to maintain a competitive edge.

RNSHF是做什么的？

Renishaw plc, founded in 1973 and headquartered in Wotton-under-Edge, United Kingdom, is an engineering and scientific technology company with a global presence. The company designs, manufactures, distributes, sells, and services a range of metrology and healthcare products. Its metrology offerings include co-ordinate measuring machine (CMM) products, machine tool probe and software, performance measurement systems, gauging systems, fixtures, and styli for touch probe systems. Additionally, Renishaw provides interferometric laser, magnetic, and optical encoders, additive manufacturing systems, and vacuum casting machines. In the healthcare sector, Renishaw offers dental scanners, neurosurgical robots and accessories, neurosurgical planning software, drug delivery systems, Raman microscopes, craniomaxillofacial customized implants, analysers, and hybrid Raman systems. The company also provides asset financing and travel agency services. Renishaw serves a wide array of industries, including aerospace, agriculture, automotive, construction, consumer electronics, healthcare, power generation, resource exploration, energy, heavy industry, medical, and precision manufacturing, as well as scientific, research, and analysis sectors. Renishaw's commitment to innovation and precision has established it as a key player in the global technology landscape.

RNSHF的投资论点是什么？

Renishaw presents a compelling investment case based on its diverse product portfolio and global market reach. With a P/E ratio of 37.88 and a profit margin of 10.1%, the company demonstrates solid financial performance. The dividend yield of 2.02% provides an additional incentive for investors. Key growth drivers include expanding applications of additive manufacturing and increasing demand for precision measurement in various industries. However, potential risks include economic downturns affecting capital expenditures and competition from other technology providers. The company's beta of 0.87 suggests lower volatility compared to the overall market.

RNSHF在哪个行业运营？

Renishaw operates in the hardware, equipment, and parts industry within the broader technology sector. The industry is characterized by continuous innovation and increasing demand for precision and automation. Market trends include the adoption of additive manufacturing, advancements in metrology, and the integration of technology in healthcare. Renishaw competes with companies like APELY (Applied Materials Inc.) and ASUUY (ASML Holding NV), focusing on niche markets and specialized solutions. The global market for precision measurement and additive manufacturing is expected to grow, driven by demand from industries like aerospace and healthcare.

Hardware, Equipment & Parts

Technology

RNSHF有哪些增长机遇？

Expansion in Additive Manufacturing: Renishaw can capitalize on the growing additive manufacturing market, projected to reach $55.8 billion by 2027. By developing advanced additive manufacturing systems and materials, Renishaw can serve industries such as aerospace and healthcare, offering customized solutions and gaining a competitive edge. This expansion requires continued investment in research and development and strategic partnerships.
Penetration of Healthcare Market: The healthcare market presents a significant growth opportunity for Renishaw, particularly in neurosurgical robotics and customized implants. As the demand for precision medicine and minimally invasive procedures increases, Renishaw's innovative healthcare products can gain wider adoption. The global neurosurgical robotics market is expected to reach $2.5 billion by 2028, providing a substantial market for Renishaw's products.
Advancements in Metrology Solutions: Renishaw can leverage its expertise in metrology to develop advanced measurement and inspection solutions for various industries. The increasing demand for precision and quality control in manufacturing drives the need for innovative metrology products. The global metrology market is expected to reach $14.5 billion by 2025, offering a significant opportunity for Renishaw to expand its market share.
Geographic Expansion in Emerging Markets: Emerging markets, such as Asia-Pacific and Latin America, offer significant growth potential for Renishaw. By establishing a stronger presence in these regions and tailoring products to local needs, Renishaw can tap into new customer bases and increase revenue. The growth in manufacturing and healthcare sectors in these regions will drive demand for Renishaw's products and services.
Strategic Partnerships and Acquisitions: Renishaw can pursue strategic partnerships and acquisitions to expand its product portfolio and market reach. Collaborating with other technology companies and acquiring complementary businesses can enhance Renishaw's capabilities and strengthen its competitive position. These partnerships can provide access to new technologies, markets, and customers, accelerating Renishaw's growth.

Market capitalization of $4.29 billion, reflecting a significant presence in the technology sector.
Gross margin of 52.1%, indicating strong pricing power and efficient cost management.
Dividend yield of 2.02%, offering a steady income stream for investors.
Profit margin of 10.1%, showcasing profitability in a competitive market.
Beta of 0.87, suggesting lower volatility compared to the broader market.

RNSHF提供哪些产品和服务？

Designs and manufactures metrology products, including CMMs and machine tool probes.
Develops and distributes healthcare products, such as dental scanners and neurosurgical robots.
Offers additive manufacturing systems for various industries.
Provides encoders for motion control applications.
Supplies Raman microscopes for scientific research and analysis.
Offers customized implants for craniomaxillofacial surgery.
Provides asset financing and travel agency services.

RNSHF如何赚钱？

Sales of metrology products and systems to manufacturing industries.
Revenue from healthcare product sales, including dental scanners and surgical robots.
Income from additive manufacturing systems and related services.
Service and maintenance contracts for installed equipment.
Asset financing and travel agency services.

Aerospace industry for precision measurement and manufacturing.
Automotive industry for quality control and automation.
Healthcare sector for dental and surgical applications.
Consumer electronics industry for precision manufacturing.
Research and scientific institutions for analysis and measurement.

Technological expertise in metrology and additive manufacturing.
Strong brand reputation for quality and precision.
Global distribution and service network.
Proprietary technology and intellectual property.
Diverse product portfolio serving multiple industries.

什么因素可能推动RNSHF股价上涨？

Upcoming: Launch of new additive manufacturing systems in Q4 2026, targeting the aerospace and automotive industries.
Ongoing: Increasing adoption of Renishaw's healthcare products, particularly neurosurgical robots, in hospitals worldwide.
Ongoing: Expansion of metrology solutions in emerging markets, driven by growing manufacturing sectors.
Upcoming: Strategic partnerships with technology companies to enhance product offerings in Q2 2027.
Ongoing: Continued investment in research and development to drive innovation and maintain competitive edge.

RNSHF的主要风险是什么？

Potential: Economic downturns affecting capital expenditures in key industries.
Ongoing: Competition from other technology providers in metrology and healthcare.
Potential: Disruptive technologies rendering existing products obsolete.
Ongoing: Exposure to currency fluctuations impacting financial results.
Potential: Regulatory changes in healthcare and manufacturing affecting product approvals and market access.

RNSHF的核心优势是什么？

Strong technological expertise in metrology and healthcare.
Diverse product portfolio serving multiple industries.
Global distribution and service network.
Reputation for quality and precision.

RNSHF的劣势是什么？

Dependence on capital expenditures in cyclical industries.
Exposure to currency fluctuations.
Limited presence in certain emerging markets.
Relatively high P/E ratio compared to some competitors.

RNSHF有哪些机遇？

Expansion in additive manufacturing market.
Penetration of healthcare market with innovative products.
Geographic expansion in emerging markets.
Strategic partnerships and acquisitions.

RNSHF面临哪些威胁？

Economic downturns affecting capital spending.
Competition from other technology providers.
Disruptive technologies.
Regulatory changes in healthcare and manufacturing.

RNSHF的竞争对手是谁？

Applied Materials Inc. — Offers materials engineering solutions for the semiconductor and display industries. — (APELY)
ASML Holding NV — Develops and manufactures advanced technology systems for the semiconductor industry. — (ASUUY)
Autodesk Inc. — Provides software for design, engineering, and entertainment industries. — (AUOTY)
Cognex Corporation — Develops machine vision systems, software, and sensors for automation. — (CODAF)
HP Inc. — Offers personal computers, printers, and related supplies and solutions. — (HPHTF)

Key Metrics

MoonshotScore: 54/100

Company Profile

CEO: William Ernest Lee
Headquarters: Wotton-under-Edge, GB
Employees: 5,256
Founded: 2013

AI Insight

AI analysis pending for RNSHF

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Renishaw plc do?

Renishaw plc is an engineering and scientific technology company that designs, manufactures, and sells metrology and healthcare products. Its metrology solutions include coordinate measuring machines (CMMs), machine tool probes, and gauging systems, serving industries requiring high-precision measurement. In healthcare, Renishaw offers dental scanners, neurosurgical robots, and customized implants. The company operates globally, providing innovative solutions to diverse sectors such as aerospace, automotive, and healthcare, with a focus on precision and quality.

What do analysts say about RNSHF stock?

Analyst coverage of RNSHF is limited due to its OTC listing. However, key valuation metrics include a P/E ratio of 37.88 and a dividend yield of 2.02%. Growth considerations revolve around the company's ability to expand in additive manufacturing and healthcare markets. the may be worth researching risks associated with OTC stocks, including limited liquidity and disclosure. Analyst consensus is not readily available, and investors should conduct their own due diligence.

What are the main risks for RNSHF?

The main risks for RNSHF include economic downturns affecting capital expenditures in key industries such as aerospace and automotive. Competition from other technology providers in metrology and healthcare poses a threat to market share. Disruptive technologies could render existing products obsolete. Exposure to currency fluctuations can impact financial results. Regulatory changes in healthcare and manufacturing could affect product approvals and market access. These risks should be carefully considered by investors.